Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Revolution in Roller Rack Apparatus Equipment for Adherent Cell Culture

Published: Friday, October 12, 2012
Last Updated: Friday, October 12, 2012
Bookmark and Share
The new WHEATON® R2P® 2.0 Roller System combines a new level of control with Ethernet networking capabilities in numerous bottle rolling configurations.

WHEATON has introduced a revolution in adherent cell culture equipment. The R2P 2.0 is the first touch screen, Ethernet network-capable roller culture device for the vaccine and biologics industry.

Designed for robustness and ease of use, units are fully configurable to meet demanding biopharmaceutical process requirements.

WHEATON roller apparatus are used worldwide for research and production of therapeutic antibodies, vaccines, proteins and cells.

The R2P 2.0 automatically controls and monitors the rotational speed of the cell culture bottles with a service-free, high precision motor.

A single apparatus can rotate up to 176 bottles. The settings on the R2P 2.0 are controlled through a color touch screen that displays all prominent process parameters and system alarms.

Parameters are accessed through readily recognizable icons and changed through intuitive configuration screens. The units are also compatible with existing networked WHEATON roller apparatus for plug and play backwards compatibility.

The WHEATON R2P 2.0 also has a USB downloadable internal event log file to record any parameter changes or alarm notifications.

Available options for the R2P 2.0 include temperature sensors and automatic battery backup to ensure an optimal environment for cell growth.

Custom configurations are available to accommodate scientists with specific requirements. International customers can specify country specific plug sets to assure electrical power supply is locally compatible.

WHEATON offers a variety of related equipment and consumables to support roller bottle cell culture.

“Careful cultivation of adherent cells in roller bottles demands a roller rack with the features we built-in to the R2P 2.0 Roller System,” said Stephen R. Drozdow, president of WHEATON.

“We strive to continually introduce advanced products with features scientists tell us they want, which is a never ending challenge as technology continues to evolve…but we’re up to it,” he added.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Key Elements to Consider when Packaging Parenteral Products
Jeffrey Reid, Global Market Manager at WHEATON® discussed the critical processes of particulate cleaning, depyrogenation, and sterilization at the recent INTERPHEX event.
Wednesday, May 18, 2016
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!